JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 163 filers reported holding JUNO THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 2.35 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $683,000 | +13.8% | 17,919 | +32.3% | 0.00% | 0.0% |
| Q4 2015 | $600,000 | +14.5% | 13,541 | +5.1% | 0.00% | 0.0% |
| Q3 2015 | $524,000 | +457.4% | 12,878 | +632.1% | 0.00% | – |
| Q2 2015 | $94,000 | -89.3% | 1,759 | -87.8% | 0.00% | -100.0% |
| Q1 2015 | $876,000 | +3269.2% | 14,446 | +2789.2% | 0.00% | – |
| Q4 2014 | $26,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 3,484 | $159,000 | 0.01% |
| Omega Fund Management, LLC | 0 | $0 | 0.00% |
| GLENMEDE TRUST CO NA | 156 | $7,000 | 0.00% |